Although NF-κB activity is associated with cancer cell growth and aggressiveness and is elevated in smoke-associated lung cancer, NF-κB remains difficult to utilize as a drug target due to its broad regulatory functions in cells. This evidence concerns the gene NFKB1 and lung cancer.